Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline- deficient medium

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 291, Issue 1, 2006, Pages

  Sahai, Atul ^a,b   Pan, Xiaomin ^a   Paul, Rachelle ^a   Malladi, Padmini ^a   Kohli, Rohit ^a   Whitington, Peter F ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c CHILDREN S MEMORIAL RESEARCH CENTER   (United States)

Author keywords

Experimental steatosis; Nonalcoholic fatty liver

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALANINE AMINOTRANSFERASE; CHOLINE; METHIONINE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; ENZYME RELEASE; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEATOSIS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; CHOLINE DEFICIENCY; CULTURE MEDIA; FATTY LIVER; HEPATOCYTES; METHIONINE; MICE; OSTEOPONTIN; SIALOGLYCOPROTEINS; TRANSAMINASES;

EID: 33745802227     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00360.2005     Document Type: Article

References (39)

1. Apte UM, Banerjee A, McRee R, Wellberg E, and Ramaiah SK. Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicol Appl Pharmacol 207: 25-38, 2005.
2. Bernard S, Touzet S, Personne I, Lapras V, Bondon PJ, Berthezene F, and Moulin P. Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes. Diabetologia 43: 995-999, 2000.
3. Borradaile NM, de Dreu LE, Barrett PH, Behrsin CD, and Huff MW. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation. Biochemistry 42: 1283-1291, 2003.
4. Borradaile NM, de Dreu LE, and Huff MW. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. Diabetes 52: 2554-2561, 2003.
5. Cassader M, Gambino R, Musso G, Depetris N, Mecca F, Cavallo-Perin P, Pacini G, Rizzetto M, and Pagano G. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids 36: 1117-1124, 2001.
6. Charlton M, Sreekumar R, Rasmussen D, Lindor K, and Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 35: 898-904, 2002.
7. Chitturi S and Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 21: 27-41, 2001.
8. Denhardt DT, Giachelli CM, and Rittling SR. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 41: 723-749, 2001.
9. Diao H, Kon S, Iwabuchi K, Kimura C, Morimoto J, Ito D, Segawa T, Maeda M, Hamuro J, Nakayama T, Taniguchi M, Yagita H, Van Kaer L, Onoe K, Denhardt D, Rittling S, and Uede T. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 21: 539-550, 2004.
10. Hemmings BA. Akt signaling: linking membrane events to life and death decisions. Science 275: 628-630, 1997.
11. Junaid A and Amara FM. Osteopontin: correlation with interstitial fibrosis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells. Histopathology 44: 136-146, 2004.
12. Kawashima R, Mochida S, Matsui A, YouLuTu ZY, Ishikawa K, Toshima K, Yamanobe F, Inao M, Ikeda H, Ohno A, Nagoshi S, Uede T, and Fujiwara K. Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun 256: 527-531, 1999.
13. Koh HS, Matsui A, Mimura S, Inao M, Saitoh E, Ohno A, Nagoshi S, Yoshimoto T, Mochida S, and Fujiwara K. Increased cytoprotective function in the liver of transgenic mice expressing osteopontin in hepatocytes. Hepatol Res 32: 46-51, 2005.
14. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, and Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105: 1067-1075, 2000.
15. Leclercq IA, Farrell GC, Schriemer R, and Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 37: 206-213, 2002.
16. Lee SH, Seo GS, Park YN, Yoo TM, and Sohn DH. Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem Pharmacol 68: 2367-2378, 2004.
17. Li XL, Man K, Ng KT, Sun CK, Lo CM, and Fan ST. The influence of phosphatidylinositol 3-kinase/Akt pathway on the ischemic injury during rat liver graft preservation. Am J Transplant 5: 1264-1275, 2005.
18. Martinez-Chantar ML, Corrales FJ, Martinez-Cruz LA, Garcia-Trevijano ER, Huang ZZ, Chen L, Kanel G, Avila MA, Mato JM, and Lu SC. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J 16: 1292-1294, 2002.
19. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, and Hughes J. Osteopontin - a molecule for all seasons. QJM 95: 3-13, 2002.
20. Mi Z, Guo H, Wai PY, Gao C, Wei J, and Kuo PC. Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior. J Biol Chem 279: 46659-46667, 2004.
21. Mimura S, Mochida S, Inao M, Matsui A, Nagoshi S, Yoshimoto T, and Fujiwara K. Massive liver necrosis after provocation of imbalance between Th1 and Th2 immune reactions in osteopontin transgenic mice. J Gastroenterol 39: 867-872, 2004.
22. Namikawa C, Shu-Ping Z, Vyselaar JR, Nozaki Y, Nemoto Y, Ono M, Akisawa N, Saibara T, Hiroi M, Enzan H, and Onishi S. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol 40: 781-786, 2004.
23. Niswender KD, Gallis B, Blevins JE, Corson MA, Schwartz MW, and Baskin DG. Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. J Histochem Cytochem 51: 275-283, 2003.
24. O'Regan A and Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 81: 373-390, 2000.
25. Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Torbenson M, Smedh U, Moran TH, Li Z, Huang J, Thomas SA, and Diehl AM. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut 53: 438-445, 2004.
26. Pappenheimer AM. The reactions of lymphocytes under various experimental conditions. J Exp Med 25: 633-650, 1917.
27. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 121: 710-723, 2001.
28. Robertson G, Leclercq I, and Farrell GC. Nonalcoholic Steatosis and Steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 281: G1135-G1139, 2001.
29. Rust C, Bauchmuller K, Fickert P, Fuchsbichler A, and Beuers U. Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers. Am J Physiol Gastrointest Liver Physiol 289: G88-G94, 2005.
30. Sahai A, Malladi P, Melin-Aldana H, Green RM, and Whitington PF. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a murine model. Am J Physiol Gastrointest Liver Physiol 287: G264-G273, 2004.
31. Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, and Whitington PF. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 287: G1035-G1043, 2004.
32. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, and Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183-1192, 2001.
33. Szanto I and Kahn CR. Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci USA 97: 2355-2360, 2000.
34. Takikawa Y, Miyoshi H, Rust C, Roberts P, Siegel R, Mandal PK, Millikan RE, and Gores GJ. The bile acid-activated phosphatidylinositol 3-kinase pathway inhibits Fas apoptosis upstream of bid in rodent hepatocytes. Gastroenterology 120: 1810-1817, 2001.
35. Wang Y, Kuropatwinski KK, White DW, Hawley TS, Hawley RG, Tartaglia LA, and Baumann H. Leptin receptor action in hepatic cells. J Biol Chem 272: 16216-16223, 1997.
36. Weltman MD, Farrell GC, and Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111: 1645-1653, 1996.
37. Whitington PF, Malladi P, Melin-Aldana H, Azzam R, Mack CL, and Sahai A. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Pediatr Res 57: 837-844, 2005.
38. Xu Z, Chen L, Leung L, Yen TS, Lee C, and Chan JY. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci USA 102: 4120-4125, 2005.
39. Zhang GX, Zhao ZQ, Wang HD, and Hao B. Enhancement of osteopontin expression in HepG2 cells by epidermal growth factor via phosphatidylinositol 3-kinase signaling pathway. World J Gastroenterol 10: 205-208, 2004.